Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Acta Neuropsychiatr ; 35(6): 315-327, 2023 Dec.
Article in English | MEDLINE | ID: mdl-36896595

ABSTRACT

Prenatal stress is believed to increase the risk of developing neuropsychiatric disorders, including major depression. Adverse genetic and environmental impacts during early development, such as glucocorticoid hyper-exposure, can lead to changes in the foetal brain, linked to mental illnesses developed in later life. Dysfunction in the GABAergic inhibitory system is associated with depressive disorders. However, the pathophysiology of GABAergic signalling is poorly understood in mood disorders. Here, we investigated GABAergic neurotransmission in the low birth weight (LBW) rat model of depression. Pregnant rats, exposed to dexamethasone, a synthetic glucocorticoid, during the last week of gestation, yielded LBW offspring showing anxiety- and depressive-like behaviour in adulthood. Patch-clamp recordings from dentate gyrus granule cells in brain slices were used to examine phasic and tonic GABAA receptor-mediated currents. The transcriptional levels of selected genes associated with synaptic vesicle proteins and GABAergic neurotransmission were investigated. The frequency of spontaneous inhibitory postsynaptic currents (sIPSC) was similar in control and LBW rats. Using a paired-pulse protocol to stimulate GABAergic fibres impinging onto granule cells, we found indications of decreased probability of GABA release in LBW rats. However, tonic GABAergic currents and miniature IPSCs, reflecting quantal vesicle release, appeared normal. Additionally, we found elevated expression levels of two presynaptic proteins, Snap-25 and Scamp2, components of the vesicle release machinery. The results suggest that altered GABA release may be an essential feature in the depressive-like phenotype of LBW rats.


Subject(s)
Depression , gamma-Aminobutyric Acid , Pregnancy , Female , Rats , Animals , gamma-Aminobutyric Acid/metabolism , Birth Weight , Glucocorticoids/metabolism , Hippocampus/metabolism , Receptors, GABA-A/metabolism
2.
J Cereb Blood Flow Metab ; 39(7): 1266-1282, 2019 07.
Article in English | MEDLINE | ID: mdl-29376464

ABSTRACT

Tonic inhibitory currents, mediated by extrasynaptic GABAA receptors, are elevated at a delay following stroke. Flavonoids minimise the extent of cellular damage following stroke, but little is known about their mode of action. We demonstrate that the flavonoid, 2'-methoxy-6-methylflavone (0.1-10 µM; 2'MeO6MF), increases GABAA receptor tonic currents presumably via δ-containing GABAA receptors. Treatment with 2'MeO6MF 1-6 h post focal ischaemia dose dependently decreases infarct volume and improves functional recovery. The effect of 2'MeO6MF was attenuated in δ-/- mice, indicating that the effects of the flavonoid were mediated via δ-containing GABAA receptors. Further, as flavonoids have been shown to have multiple modes of action, we investigated the anti-inflammatory effects of 2'MeO6MF. Using a macrophage cell line, we show that 2'MeO6MF can dampen an LPS-induced elevation in NFkB activity. Assessment of vehicle-treated stroke animals revealed a significant increase in circulating IL1ß, TNFα and IFγ levels. Treatment with 2'MeO6MF dampened the stroke-induced increase in circulating cytokines, which was blocked in the presence of the pan-AKT inhibitor, GSK690693. These studies support the hypothesis that compounds that potentiate tonic inhibition via δ-containing GABAA receptors soon after stroke can afford neuroprotection.


Subject(s)
Brain Ischemia/drug therapy , Flavones/administration & dosage , GABA Modulators/administration & dosage , Neuroprotective Agents/administration & dosage , Animals , Brain/metabolism , Disease Models, Animal , Flavones/pharmacokinetics , Male , Mice , Mice, Inbred BALB C , Mice, Knockout , Receptors, GABA-A/drug effects , Receptors, GABA-A/genetics , Receptors, GABA-A/physiology , Stroke/drug therapy , Synaptic Potentials/drug effects , Synaptic Potentials/physiology
3.
Hippocampus ; 27(11): 1168-1177, 2017 11.
Article in English | MEDLINE | ID: mdl-28686803

ABSTRACT

Synaptotagmin 1 is a presynaptic calcium sensor, regulating SNARE-mediated vesicle exocytosis of transmitter. Increasing evidence indicate roles of SNARE proteins in postsynaptic glutamate receptor trafficking. However, a possible postsynaptic expression of synaptotagmin 1 has not been demonstrated previously. Here, we used postembedding immunogold electron microscopy to determine the subsynaptic localization of synaptotagmin 1 in rat hippocampal CA1 Schaffer collateral synapses. We report for the first time that synaptotagmin 1 is present in rat hippocampal postsynaptic spines, both on cytoplasmic vesicles and at the postsynaptic density. We further investigated whether postsynaptic synaptotagmin 1 is regulated during synaptic plasticity. In a rat model of chronic temporal lobe epilepsy, we found that presynaptic and postsynaptic concentrations of the protein are reduced compared to control animals. This downregulation may possibly be an adaptive measure to decrease both presynaptic and postsynaptic calcium sensitivity in excitotoxic conditions.


Subject(s)
Cytoplasmic Vesicles/metabolism , Dendritic Spines/metabolism , Hippocampus/metabolism , Post-Synaptic Density/metabolism , Synaptotagmin I/metabolism , Animals , Cells, Cultured , Chronic Disease , Cytoplasmic Vesicles/ultrastructure , Dendritic Spines/ultrastructure , Disease Models, Animal , Down-Regulation , Epilepsy, Temporal Lobe/metabolism , Epilepsy, Temporal Lobe/pathology , Hippocampus/ultrastructure , Immunohistochemistry , Kainic Acid , Male , Mice, Knockout , Microscopy, Electron , Post-Synaptic Density/ultrastructure , Presynaptic Terminals/metabolism , Presynaptic Terminals/ultrastructure , Rats, Sprague-Dawley , Rats, Wistar , Synaptotagmin I/deficiency , Synaptotagmin I/genetics
4.
Eur J Neurosci ; 43(2): 169-78, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26547631

ABSTRACT

In contrast to tonic extrasynaptic γ-aminobutyric acid (GABA)A receptor-mediated signalling, the physiological significance of tonic extrasynaptic N-methyl-D-aspartate (NMDA) receptor (NMDAR)-mediated signalling remains uncertain. In this study, reversible open-channel blockers of NMDARs, memantine and phencyclidine (PCP) were used as tools to examine tonic NMDAR-mediated signalling in rat hippocampal slices. Memantine in concentrations up to 10 µM had no effect on synaptically evoked NMDAR-mediated responses in pyramidal neurons or GABAergic interneurons. On the other hand, 10 µM memantine reduced tonic NMDAR-mediated currents in GABAergic interneurons by approximately 50%. These tonic NMDAR-mediated currents in interneurons contributed significantly to the excitability of the interneurons as 10 µM memantine reduced the disynaptic inhibitory postsynaptic current in pyramidal cells by about 50%. Moreover, 10 µM memantine, but also PCP in concentrations ≤ 1 µM, increased the magnitude of the population spike, likely because of disinhibition. The relatively higher impact of tonic NMDAR-mediated signalling in interneurons was at least partly explained by the expression of GluN2D-containing NMDARs, which was not observed in mature pyramidal cells. The current results are consistent with the idea that low doses of readily reversible NMDAR open-channel blockers preferentially inhibit tonically active extrasynaptic NMDARs, and they suggest that tonically active NMDARs contribute more prominently to the intrinsic excitation in GABAergic interneurons than in pyramidal cells. It is proposed that this specific difference between interneurons and pyramidal cells can explain the disinhibition caused by the Alzheimer's disease medication memantine.


Subject(s)
CA1 Region, Hippocampal/physiology , GABAergic Neurons/physiology , Interneurons/physiology , Pyramidal Cells/physiology , Receptors, N-Methyl-D-Aspartate/physiology , Synaptic Potentials , Animals , CA1 Region, Hippocampal/drug effects , Cerebrospinal Fluid/physiology , Culture Media/pharmacology , Excitatory Postsynaptic Potentials/drug effects , Female , GABAergic Neurons/drug effects , Humans , Inhibitory Postsynaptic Potentials/drug effects , Interneurons/drug effects , Male , Memantine/pharmacology , Neural Inhibition/drug effects , Phencyclidine/pharmacology , Pyramidal Cells/drug effects , Rats , Receptors, N-Methyl-D-Aspartate/drug effects , Receptors, N-Methyl-D-Aspartate/metabolism , Synaptic Potentials/drug effects
5.
Neuropharmacology ; 63(3): 469-79, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22579928

ABSTRACT

δ-subunit containing extrasynaptic GABA(A) receptors are potential targets for modifying neuronal activity in a range of brain disorders. With the aim of gaining more insight in synaptic and extrasynaptic inhibition, we used a new positive modulator, AA29504, of δ-subunit containing GABA(A) receptors in mouse neurons in vitro and in vivo. Whole-cell patch-clamp recordings were carried out in the dentate gyrus in mouse brain slices. In granule cells, AA29504 (1 µM) caused a 4.2-fold potentiation of a tonic current induced by THIP (1 µM), while interneurons showed a potentiation of 2.6-fold. Moreover, AA29504 (1 µM) increased the amplitude and prolonged the decay of miniature inhibitory postsynaptic currents (mIPSCs) in granule cells, and this effect was abolished by Zn²âº (15 µM). AA29504 (1 µM) also induced a small tonic current (12.7 ± 3.2 pA) per se, and when evaluated in a nominally GABA-free environment using Ca²âº imaging in cultured neurons, AA29504 showed GABA(A) receptor agonism in the absence of agonist. Finally, AA29504 exerted dose-dependent stress-reducing and anxiolytic effects in mice in vivo. We propose that AA29504 potentiates δ-containing GABA(A) receptors to enhance tonic inhibition, and possibly recruits perisynaptic δ-containing receptors to participate in synaptic phasic inhibition in dentate gyrus.


Subject(s)
GABA Agents/pharmacology , GABA Agonists/pharmacology , Neurons/drug effects , Neurons/physiology , Receptors, GABA-A/physiology , Animals , Anxiety/drug therapy , Anxiety/psychology , Brain/metabolism , Calcium/metabolism , Data Interpretation, Statistical , Dentate Gyrus/cytology , Dentate Gyrus/drug effects , Electrophysiological Phenomena , Fever/etiology , GABA Agents/metabolism , Isoxazoles/pharmacology , Male , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Patch-Clamp Techniques , Pyramidal Cells/drug effects , Radioligand Assay , Receptors, GABA-A/drug effects , Stress, Psychological/physiopathology , Synaptic Transmission/drug effects
6.
Epilepsy Res ; 90(1-2): 39-46, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20363598

ABSTRACT

Human and murine succinic semialdehyde dehydrogenase (SSADH; gamma-hydroxybutyric (GHB) aciduria) deficiency represents an epileptic disorder associated with hyperGABA- and hyperGHB-ergic states. Despite significant neurotransmitters alterations, well-defined single-cell electrophysiological studies, aimed to provide insight into regional neuropathology, have been lacking. In this study, we characterized the effect of residual SSADH enzyme function/increased GABA levels on single-cell hippocampal electrophysiology in SSADH+/+ (wild-type; WT), SSADH+/- (heterozygous; HET), and SSADH-/- (knock-out; KO) mice. Tonic extrasynaptic GABAA receptor (GABAAR)-mediated currents were elevated in HET and KO mice, whereas phasic synaptic GABAAR currents were unaltered in dentate gyrus granule cells. Similarly, tonic GABAAR-mediated currents were increased in dentate gyrus interneurons of KO animals, while phasic GABAergic neurotransmission was unaffected in the same cells. Our results indicate global disruption of cortical networks in SSADH KO mice, affecting both excitatory and inhibitory neurons. Our findings provide new clues concerning seizure evolution in the murine model (absence-->tonic-clonic-->status epilepticus), and extend pathophysiological insight into human SSADH deficiency.


Subject(s)
Gene Dosage/genetics , Hippocampus/pathology , Membrane Potentials/genetics , Neurons/physiology , Seizures , Succinate-Semialdehyde Dehydrogenase/deficiency , Animals , Animals, Newborn , Biophysics , Disease Models, Animal , Dose-Response Relationship, Drug , Electric Stimulation/methods , Female , GABA Antagonists/pharmacology , Humans , In Vitro Techniques , Linear Models , Lysine/analogs & derivatives , Male , Membrane Potentials/drug effects , Mice , Mice, Knockout , Neurons/classification , Neurons/drug effects , Patch-Clamp Techniques/methods , Pyridazines/pharmacology , Seizures/genetics , Seizures/pathology , Seizures/physiopathology , gamma-Aminobutyric Acid/metabolism
7.
J Neurophysiol ; 100(1): 526-32, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18463187

ABSTRACT

Activity of extrasynaptic GABA A receptors mediating tonic inhibition is thought to play an important role for the excitability of the mammalian cerebral cortex. However, little is known about the cell type-specific expression of tonic inhibition in particular types of cortical interneurons. Here, we used transgenic mice expressing green fluorescent protein (GFP) in somatostatin-positive (SOM) interneurons and investigated tonic inhibition in SOM interneurons versus pyramidal cells in neocortical layers 2/3. In brain slices, pyramidal cells showed a tonic current of 66 +/- 19 pA in response to the delta-subunit selective GABA A agonist THIP (1 microM). On the other hand, tonic inhibition was absent in SOM interneurons (8 +/- 1 pA) in response to THIP. As opposed to pyramidal cells, SOM interneurons were also insensitive to the delta-subunit preferring neurosteroid allotetrahydrodeoxycorticosterone (THDOC) (100 nM) and to elevated endogenous GABA levels in the slice. Finally, SOM interneurons received only 45% of the phasic charge transfer during GABA A receptor-mediated synaptic activity compared with pyramidal cells. Altogether, our study indicates that SOM interneurons receive relatively weak inhibitory input and cannot be brought under the influence of tonic inhibition.


Subject(s)
Neocortex/cytology , Neural Inhibition/physiology , Neurons/classification , Neurons/physiology , Receptors, GABA-A/physiology , Anesthetics/pharmacology , Animals , Animals, Newborn , Desoxycorticosterone/analogs & derivatives , Desoxycorticosterone/pharmacology , Drug Interactions , GABA Agonists/pharmacology , GABA Antagonists/pharmacology , In Vitro Techniques , Inhibitory Postsynaptic Potentials/drug effects , Inhibitory Postsynaptic Potentials/physiology , Inhibitory Postsynaptic Potentials/radiation effects , Isoxazoles/pharmacology , Mice , Neural Inhibition/drug effects , Neurons/drug effects , Patch-Clamp Techniques/methods , Reaction Time/drug effects , gamma-Aminobutyric Acid/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...